Pactiv Evergreen reported a decrease in net revenues and a significant net loss due to a $322 million impairment charge from the Mill Transaction. However, the company increased adjusted EPS through cost management and resource optimization.
Net revenues decreased by 3% year-over-year to $1,333 million.
Net loss from continuing operations was $213 million, or $1.18 per diluted share, compared to net income of $28 million, or $0.15 per diluted share, in the third quarter of 2023.
Adjusted EBITDA was $214 million, compared to $227 million in the third quarter of 2023.
Adjusted EPS increased to $0.36 from $0.32 in the third quarter of 2023.
Pactiv Evergreen is updating its existing guidance range for full year 2024 Adjusted EBITDA to a range of $800 million to $810 million.
Visualization of income flow from segment revenue to net income